Injections are considered the gold standard in treating people with type 1 diabetes, and becoming a part of the preferred treatment method for people with type 2 diabetes. However, a recent survey commissioned by the AADE, showed that 57% of patients admitted to readily omitting their insulin injections on occasion, and 47% would be more likely to administer their injections regularly if a product was available to ease the pain and discomfort of injections.
IPT helps directly address these findings by providing a tool to help patients forget about the pain and anxiety associated with each skin puncture.

These benefits enable patients to focus on initiating injection therapy or improving their current injection treatment regimen. As a result, healthcare professionals are finding that Injection Port Therapy (IPT) is an effective treatment option for both type 1 and type 2 patients taking multiple daily injections.